REGENXBIO, Inc. (RGNX)
8.22
+0.13
(+1.61%)
USD |
NASDAQ |
Oct 09, 13:20
REGENXBIO Price : 8.22 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 7.50 | 8.31 | 7.44 | 8.09 | 2.259M |
| Oct 07, 2026 | 7.31 | 7.73 | 7.20 | 7.595 | 1.005M |
| Oct 06, 2026 | 7.79 | 7.84 | 7.33 | 7.45 | 1.164M |
| Oct 05, 2026 | 7.80 | 8.16 | 7.57 | 7.76 | 2.354M |
| Oct 02, 2026 | 7.58 | 7.62 | 7.36 | 7.43 | 1.037M |
| Oct 01, 2026 | 7.52 | 7.736 | 7.30 | 7.42 | 1.705M |
| Sep 30, 2026 | 7.49 | 7.86 | 7.35 | 7.53 | 1.789M |
| Sep 29, 2026 | 7.41 | 7.64 | 7.33 | 7.45 | 2.096M |
| Sep 28, 2026 | 7.30 | 7.495 | 7.170 | 7.47 | 1.326M |
| Sep 25, 2026 | 7.53 | 7.675 | 7.165 | 7.40 | 1.277M |
| Sep 24, 2026 | 7.45 | 7.46 | 7.12 | 7.24 | 1.516M |
| Sep 23, 2026 | 8.13 | 8.145 | 7.40 | 7.50 | 1.113M |
| Sep 22, 2026 | 8.03 | 8.25 | 7.904 | 8.15 | 1.202M |
| Sep 21, 2026 | 8.24 | 8.313 | 7.76 | 7.88 | 1.116M |
| Sep 18, 2026 | 8.22 | 8.331 | 8.00 | 8.03 | 3.375M |
| Sep 17, 2026 | 8.34 | 8.56 | 8.02 | 8.215 | 1.808M |
| Sep 16, 2026 | 7.93 | 7.99 | 7.636 | 7.98 | 1.232M |
| Sep 15, 2026 | 8.69 | 8.75 | 7.78 | 7.945 | 1.427M |
| Sep 14, 2026 | 8.58 | 8.728 | 8.49 | 8.69 | 858446.0 |
| Sep 11, 2026 | 8.69 | 8.82 | 8.39 | 8.53 | 1.029M |
| Sep 10, 2026 | 8.63 | 8.79 | 8.47 | 8.56 | 1.172M |
| Sep 09, 2026 | 8.70 | 9.025 | 8.62 | 8.73 | 1.408M |
| Sep 08, 2026 | 8.95 | 8.95 | 8.60 | 8.76 | 998960.0 |
| Sep 04, 2026 | 9.09 | 9.215 | 8.86 | 8.94 | 1.071M |
| Sep 03, 2026 | 9.56 | 9.56 | 9.00 | 9.20 | 839249.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 277.39 |
| United Therapeutics Corp. | 549.93 |
| Ardelyx, Inc. | 3.28 |
| Biomea Fusion, Inc. | 1.42 |
| RenovoRx, Inc. | 1.27 |
Price Related Metrics
| PS Ratio | 2.460 |
| PEG Ratio | -0.2347 |
| Price to Book Value | 6.204 |
| Earnings Yield | -46.05% |
| Market Cap | 445.23M |
| PEGY Ratio | -0.2347 |